Common pathways included pathways in cancer, ERK signaling, and dopamine D2 receptor transactivation of EGFR. HGF signaling, TGFβ receptor signaling, and apoptotic pathways were unique to IDH1 mt tumors. This evidence concerns the gene DRD2 and cancer.